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Abstract
Introduction
Neurological involvement is one of the most important clinical manifestations of syphilis and
neurological disease occurs in both early and late syphilis. The impact of HIV co-infection on
clinical neurosyphilis remains unclear. The highest prevalence of both syphilis and HIV is in
Africa. Therefore it might be expected that neurosyphilis would be an important and not
uncommon manifestation of syphilis in Africa and frequently occur in association with HIV
co-infection; yet few data are available on neurosyphilis in Africa. The aim of this study is to
review data on neurosyphilis in Africa since the onset of the HIV epidemic.
Methods
We searched the literature for references on neurosyphilis in Africa for studies published
between the 1st of January 1990 and 15th February 2017. We included case reports, case
series, and retrospective and prospective cohort and case-control studies. We did not limit
inclusion based on the diagnostic criteria used for neurosyphilis. For retrospective and pro-
spective cohorts, we calculated the proportion of study participants who were diagnosed
with neurosyphilis according to the individual study criteria. Depending on the study, we
assessed the proportion of patients with syphilis found to have neurosyphilis, and the pro-
portion of patients with neurological syndromes who had neurosyphilis. Due to heterogene-
ity of data no formal pooling of the data or meta-analysis was undertaken.
Results
Amongst patients presenting with a neurological syndrome, three studies of patients with
meningitis were identified; neurosyphilis was consistently reported to cause approximately
3% of all cases. Three studies on stroke reported mixed findings but were limited due to the
small number of patients undergoing CSF examination, whilst neurosyphilis continued to be
reported as a common cause of dementia in studies from North Africa. Ten studies reported
on cases of neurosyphilis amongst patients known to have syphilis. Studies from both North
and Southern Africa continue to report cases of late stage syphilis, including tabes dorsalis
and neurosyphilis, in association with ocular disease.
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Discussion
This is the first systematic review of the literature on neurosyphilis in Africa since the begin-
ning of the HIV epidemic. Neurosyphilis continues to be reported as a manifestation of both
early and late syphilis, but the methodological quality of the majority of the included studies
was poor. Future well-designed prospective studies are needed to better delineate the inci-
dence and clinical spectrum of neurosyphilis in Africa and to better define interactions with
HIV in this setting.
Author summary
Involvement of the central nervous system is an important manifestation of syphilis
which may be more common in patients co-infected with HIV. As most cases of syphilis
and HIV are seen in Africa it might be anticipated that neurosyphilis was common there.
We reviewed all published material on neurosyphilis in Africa since 1990. There were few
well designed studies of neurosyphilis. A small number of studies suggested that syphilis
remains a cause of meningitis in Africa. Our data suggest that neuosyphilis remains an
important disease in Africa but better prospective studies are needed to understand its
epidemiology.
Introduction
Syphilis, caused by Treponema pallidum subsp. pallidum, remains an important sexually trans-
mitted disease worldwide. Some studies suggest the natural history, outcomes of treatment,
and likelihood of central nervous system involvement are different in HIV-infected compared
to uninfected individuals [1–3], but consensus has not been reached [4]. Globally the highest
rates of syphilis and HIV are in Africa[5]. Based on this and the potential for interaction with
HIV in the region, it might be expected that neurosyphilis would be an important and not
uncommon manifestation of syphilis in Africa, yet few data are available.
Neurological involvement is one of the most important manifestations of syphilis. Typically
neurosyphilis is described as a late manifestation, but neuroinvasion and neurological disease
occur in both early and late syphilis[6], and T.pallidum may be frequently identified in the CSF of
patients with early stage syphilis[7]. The clinical spectrum seen ranges from asymptomatic neu-
roinvasion, meningitis, meningovascular disease presenting as a stroke-like syndrome, and the
late stage manifestations of tertiary syphilis: tabes dorsalis and general paresis of the insane[8].
Cerebrospinal fluid (CSF) is frequently abnormal in patients with neurosyphilis with both
pleocytosis and raised protein concentration. The Venereal Disease Research Laboratory
(VDRL) assay on CSF is normally considered the gold standard for specificity, but is recog-
nised to have limited sensitivity [9,10]. Other CSF tests, including serological assays, such as
the Rapid Plasma Reagin (RPR)[11], Fluorescent Treponemal Antibody-adsorption
(FTA-ABS)[12] and Treponema pallidum haemagglutination assay[13]and molecular assays
including PCR[14] have all been assessed for CSF and have variable specificity and sensitivity
for the diagnosis of neurosyphilis. Difficulties in interpretation of CSF pleocytosis in individu-
als co-infected with HIV add to challenges in evaluating the relationship between the two dis-
eases. CSF pleocytosis is seen in individuals with either infection alone [4,14], thus discerning
the cause of pleocytosis in co-infected individuals is not possible.
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The aim of this study is to review data on neurosyphilis in Africa since the onset of the HIV
epidemic.
Methods
Search strategy and selection criteria
We searched Pubmed, Medline, EMBASE and the grey literature for references on neurosyphi-
lis in Africa. We searched reference lists of selected papers to identify additional references.
We searched for (“CSF” OR “lumbar puncture” OR “meningitis” OR “meningovascular” OR
“stroke”) AND “syphilis”) OR (“neurosyphilis” OR “tabes dorsalis” OR “general paresis”)
AND (Africa OR each individual country in Africa). We limited the search to studies pub-
lished between 1st of January 1990 and 15th February 2017 (the date the search was conducted).
No language restrictions were placed. We excluded reviews if they did not report new primary
material, studies limited purely to comparisons of diagnostic techniques, studies on non-neu-
rological manifestations of syphilis, studies reporting cases occurring before 1990, and studies
reporting patients already described in a different paper.
Data extraction
For each reference we extracted the number of sites in each study, the duration of the study,
inclusion and exclusion criteria, diagnostic criteria for neurosyphilis, the clinical syndromes,
and the number of HIV infected and uninfected individuals. We also extracted information on
the treatment and outcomes of patients in these studies.
Statistical analysis
For retrospective and prospective cohorts, we calculated the proportion of study participants
who were diagnosed with neurosyphilis according to the individual study criteria. Depending
on the study, we assessed the proportion of patients with syphilis found to have neurosyphilis,
and the proportion of patients with neurological syndromes who had neurosyphilis. Due to
heterogeneity of data no formal pooling of the data or meta-analysis was undertaken.
Results
We identified 189 citations of which 42 met our inclusion criteria (Fig 1) (Tables 1–3).
Case reports
Twenty-one case reports including 37 patients were identified [15–35]. The clinical syndromes
included focal neurological manifestations such as cranial nerve involvement and including
range of manifestations including meningitis, meningovascular syphilis, tabes dorsalis and
dementia (Table 1).
Patients presenting with a neurological syndrome
Eleven studies reported data on patients presenting with neurological syndromes (Table 2).
The methodological quality of many of these studies was poor (Table 4). At least one major
methodological limitation was identified in half. Six studies were retrospective (54.5%) and
only eight (72.7%) included the performance of lumbar punctures to make the diagnosis of
neurosyphilis. Several studies did not provide clear diagnostic criteria for neurosyphilis and,
even in studies where LP was performed, it was frequently not performed on all patients
enrolled in the study.
Neurosyphilis in Africa
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Dementia. In a single-centre retrospective study from Morocco of 563 patients attending
a dementia clinic between 2000–2013 neurosyphilis was reported to be the most common
infectious cause of dementia identified, and accounted for 3.6% of all cases of dementia seen
during the study period[36]. Details on CSF diagnostics were not provided, so the proportion
of these cases which were definitive neurosyphilis is not known.
Seizures. A retrospective study in Ethiopia of individuals aged over 13 presenting with
status epilepticus enrolled a total of 119 patients but only 25 (21%) patients underwent CSF
testing for neurosyphilis[37]. In this subgroup a diagnosis of neurosyphilis was made in 2
patients on the basis of a positive CSF VDRL (8%).
In a prospective study in Zambia[38], HIV infected patients with a new onset of seizures
were enrolled and underwent CSF testing within two weeks of the index seizure. Three patients
had a reactive serum RPR and TPHA, but no individual had a positive CSF VDRL.
Stroke. In a retrospective study from Morocco of adults aged 18–45 (n = 128) presenting
with stroke the underlying diagnosis was reported to be meningovascular syphilis in 14
patients (11%). However CSF diagnostics were not undertaken and syphilis was diagnosed on
the basis of serum serological testing, so the proportion of these cases which were definitive
neurosyphilis is unknown. [39].
Two prospective studies conducted in Malawi and Sudan enrolled patients presenting with
stroke (n = 98 and n = 96 respectively)[40,41]. Lumbar punctures were performed and a posi-
tive CSF VDRL was considered diagnostic in both studies. In the study in Malawi [40] 48% of
patients were HIV positive. Fifty nine individuals had serum syphilis serology performed.
Thirteen patients had a positive TPPA and a negative VDRL and a further five patients had
both a positive TPPA and a VDRL. CSF VDRL testing was negative in all patients with positive
serological tests on blood. In the study in Sudan both serological and CSF evidence of syphilis
were assessed and a positive CSF-VDRL was considered diagnostic of neurosyphilis [41]. The
prevalence of HIV was not stated for patients enrolled in the study. Syphilis was identified as
Fig 1. Study inclusion flowchart.
https://doi.org/10.1371/journal.pntd.0005880.g001
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the major risk factor for stroke in four patients (4.2%) but no details were given as to whether
this was based on serum testing alone or on CSF testing.
A case-control study of stroke conducted in Tanzania between 2003–2006 enrolled 158
stroke cases and 369 age- and sex- matched controls[42]. Serology for syphilis was performed
using an IgG ELISA (Treponema pallidum IgG ELISA; IBL international GmbH, Hamburg,
Germany). The seroprevalence was significantly higher in stroke cases (24.7%) compared to
controls (12.7%) and a positive ELISA was associated with a significantly increased risk of
stroke (OR 2.8, 95% CI 1.6–4.6). No CSF testing was performed in this study so it is not clear
whether this association represents causation and, if so, whether the mechanism is meningo-
vascular syphilis.
Meningitis. Prospective and retrospective studies in South Africa, and a further prospec-
tive study in Uganda, enrolled patients with clinically suspected meningitis. In the prospective
South African study, sixty consecutive patients with clinically suspected meningitis were
enrolled[43]. The overall seroprevalence for HIV was 68%. Of the 60 enrolled patients a micro-
biological diagnosis was made in 39 (65%). Meningococcal meningitis accounted for ten cases.
Tuberculous meningitis and cryptococcal meningitis each accounted for nine cases. On the
basis of a positive CSF RPR and TPHA two cases of neurosyphilis were diagnosed (3.3%)–one
with an oculomotor nerve palsy and one with cryptococcal co-infection.
Table 1. Case reports of neurosyphilis—Clinical and diagnostic features.
Study Country n Year CSF Criteria for Diagnosis of
Neurosyphilis
Clinical Syndrome % HIV Positive
Patients
Wolf B[15] Zimbabwe 2 1993 RPR / TPHA One case of early meningitic disease & one case of
paranchymatous disease
0%
Silber E—1998
[16]
South Africa 7 1998 VDRL Meningitis 14% (n = 1)
Bulundwe KK[17] South Africa 1 2000 VDRL Meningitis 100%
Nunes da Silva
MJ[18]
Guinea-
Bissau
1 2000 VDRL / TPHA Meningitis 0%
Seydi M[19] Senegal 1 2001 VDRL / TPHA Meningitis 100%
Corr P[20] South Africa 1 2004 VDRL / FTA Meningovascular 100%
Zouhair K[21] Morocco 4 2004 Not Stated Tabes Dorsalis 0%
Harifi G[22] Morocco 1 2009 TPHA / VDRL Trigeminal Neuralgia Not Stated
Salami AK[23] Nigeria 1 2009 VDRL Meningovascular 100%
Mrabet D[24] Tunisia 1 2010 VDRL Tabes Dorsalis 0%
Kyebambe PS[25] Uganda 1 2010 VDRL Meningovascular 100%
Wasserman S[26] South Africa 1 2011 VDRL Guillan-Barre Syndrome 0%
Mebrouk Y[27] Morocco 1 2011 VDRL / TPHA Spinal Meningitis 0%
Napon C[28] Burkina
Faso
1 2012 VDRL / TPHA Focal Neurology 0%
Derouich I[29] Morocco 1 2013 VDRL / TPHA Limbic Encephalitis 0%
Samia M[30] Morocco 1 2013 Syphilis serology not otherwise
specified
Tabes Dorsalis 0%
Lakjiri S[31] Morocco 1 2014 Syphilis serology not otherwise
specified
Tabes Dorsalis 0%
Moolla Y[32] South Africa 1 2016 VDRL Psychosis 0%
Hajjaj I[33] Morocco 1 2010 TPHA / VDRL Meningitis 0%
Bourazza A[34] Morocco 5 2008 VDRL Meningovascular 0%
Hsaini Y[35] Morocco 3 2010 Syphilis serology not otherwise
specified
Tabes Dorsalis 0%
https://doi.org/10.1371/journal.pntd.0005880.t001
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Table 3. Patients with syphilis investigated for neurosyphilis—Inclusion criteria, clinical and diagnostic features.
Study Country n Year Study Design Study
Duration
Study
Inclusion
Criteria
CSF Criteria
for Diagnosis
of
Neurosyphilis
Neurosyphilis
Syndrome
Prevalence of
Neurosyphilis
% HIV
Positive
Patients
Yahyaoui M
[47]
Morroco 201 2005 Retrospective 10 years Clinical
diagnosis of
Neurosyphilis
with positive
CSF serology
VDRL or
TPHA
Dementia n = 145
Meningovascular
n = 45
Tabes dorsalis
n = 20
Ocular Syphilis
n = 13
Other n = 21
100% 29 Patients
tested with
prevalence
6.9%
Rafai M.A
[48]
Morocco 55 2012 Retrospective 12 Years Clinical
diagnosis of
Neurosyphilis
with positive
CSF serology
Syphilis
Serology not
otherwise
specified
General Paresis
of the Insane
n = 24
Meningovascular
Syphilis n = 20
Tabes Dorsalis
n = 9
Other n = 3
100% 0%
Allali F[49] Morocco 24 2006 Retrospective 20 years Arthropathy
due to Tabes
Dorsalis
Treponemal
Antibodies
Tabes Dorsalis 33.30% 0%
Timmermans
M[50]
South Africa 161 2004 Retrospective 10 years Positive CSF
FTA
CSF FTA Dementia n = 82
Stroke n = 24
Spinal cord
disease n = 15
Seizures n = 14
100% 0%
Molepo J[51] South Africa 50 2007 Prospective 15
Months
Suspected
Neurosyphilis
VDRL / FTA 80%^ Not Stated
Cisse A—
2002[52]
Guinea 28 2002 Retrospective 8 Years Neurosyphilis
with focal
neurology
VDRL / TPHA Focal neurology* 100% 0%
Reekie I[53] South Africa 31 2016 Retrospective 20
months
Patients with
clinical Ocular
Syphilis
CSF
Pleocytosis /
FTA
Ocular Syphilis 25.80% 50% of
patients with
Neurosyphilis
Tattevin P
[54]
Mozambique 21 2002 Prospective 20
Months
Latent
Syphilis in
HIV positive
patients
Protein
>50mg/dl
WBC > 5/mm
Positive CSF
RPR test
Asymptomatic
Neurosyphilis
19% 100%
Nnoruka EN
[55]
Nigeria 31 2005 Prospective 8 Months Patients with
HIV & Syphilis
seen in
Dermatology
Clinic
VDRL Asymptomatic
Neurosyphilis
0% 100%
Modi G[56] South Africa 506 2007 Prospective 6 Months All HIV
Positive
Patients
Syphilis
Serology not
otherwise
specified
Asymptomatic
Neurosyphilis
0.20% 100%
^ A further 10% of patients negative by serology were reported to be PCR positive for T.pallidum in CSF
* The study authors report that as well as these ’atypical cases’ they 11 cases of Tabes dorsalis, 4 cases of syphilis meningitis, 8 cases of meningovascular
syphilis and 13 cases of general paresis of the insane
https://doi.org/10.1371/journal.pntd.0005880.t003
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In the retrospective study from South Africa[44], 4,961 episodes of suspected meningitis
were included. Neurosyphilis was diagnosed on the basis of a reactive CSF TPHA or VDRL.
Of the total population studied, 2,293 were found to have normal CSF and a further 931
patients were found to have changes compatible with HIV alone. Of the 1,737 individuals who
had an LP compatible with meningitis a microbiological diagnosis was made in 820 patients
Table 4. Methodological assessment of criteria used for diagnosis of neurosyphilis.
Study Study
Methodology
Criteria for diagnosis of Neurosyphilis
LP required
for
diagnosis
LP performed
on all patients
Testing for
Neurosyphilis
Performed on all CSF
samples
CSF
Diagnostic
Criteria Stated
Benabdeljili M
[36]
Retrospective Yes Yes Yes Not Clearly
Defined
Amare A[37] Retrospective Not Stated No No Clearly
Defined
Siddiqi OK[38] Prospective Yes Yes Yes Clearly
Defined
Chraa M[39] Retrospective No Testing Not
Peformed
Testing Not Peformed Not Performed
Kumwenda JJ
[40]
Prospective Yes No Yes Clearly
Defined
Sokrab TE[41] Prospective Not Stated Not Stated Not Stated Clearly
Defined
de Mast Q[42] Prosepctive
Case Conrol
Study
No Testing Not
Peformed
Testing Not Peformed Not Performed
Silber E—
1999[43]
Prospective Yes Yes Yes Clearly
Defined
Jarvis J[44] Retrospective Yes Yes No Clearly
Defined
Rajasingham
R[45]
Prospective Yes Yes Yes Clearly
Defined
Szabo I[46] Prospecive Not stated No Not stated Not Clearly
Defined
Yahyaoui M
[47]
Retrospective Yes Yes Yes Clearly
Defined
Rafai M.A [48] Retrospective Yes Yes Yes Not Clearly
Defined
Allali F[49] Retrospective Yes Yes Yes Not Clearly
Defined
Timmermans
M[50]
Retrospective Yes Yes Yes Clearly
Defined
Molepo J[51] Prospective Yes Yes Yes Clearly
Defined
Cisse A—
2002[52]
Retrospective Yes Yes Yes Clearly
Defined
Reekie I[53] Retrospective Yes No No Clearly
Defined
Tattevin P[54] Prospective Yes Yes Yes Clearly
Defined
Nnoruka EN
[55]
Prospective Not Stated Not Stated Not Stated Clearly
Defined
Modi G[56] Prospective Yes Not Stated Not Stated Not Clearly
Defined
https://doi.org/10.1371/journal.pntd.0005880.t004
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(47%). A diagnosis of neurosyphilis was made in 22 patients (1.26% of patients with an abnor-
mal CSF, 3% of patients with a microbiological diagnosis). Testing for neurosyphilis was per-
formed at the physician’s discretion and this is likely to be an underestimate of the true
proportion of cases caused by neurosyphilis.
In Uganda samples were obtained from patients enrolled in a study ART initiation in HIV
positive patients with cryptococcal meningitis [45]. A total of 63 patients negative for Crypto-
coccus in CSF and 54 patients with Cryptococcal meningitis were assessed. The overall syphilis
seroprevalence in these patients was not stated but neurosyphilis was diagnosed in 3 of 111
(2.7%) patients who were tested on the basis of a positive CSF VDRL, accounting for a compa-
rable number of cases as bacterial meningitis (Streptococcus pneumoniae n = 4, Neisseria
meningitidis n = 1).
Other. In a study conducted at a single site in Uganda and a single site in Kenya, a total of
288 consecutive patients with neurological symptoms were enrolled[46]. All patients under-
went a neurological examination but detailed information was not provided on the clinical
abnormalities seen. The overall prevalence of HIV was 12.2%. A total of 87 patients underwent
CSF testing. Neurosyphilis was the diagnosis in 32 (11.1%) although the proportion of patients
who had a diagnosis based on a positive CSF test was not reported, nor was the overall preva-
lence of syphilis in the study population given.
Studies on neurosyphilis amongst patients with syphilis
Ten studies reported on cases of neurosyphilis amongst patients known to have syphilis
(Table 3). The methodological quality of many studies was poor with at least one significant
methodological weakness in all but one study (Table 4). The study design was retrospective for
six of the studies (60%) whilst lumbar puncture was performed in only seven studies (70%) for
the diagnosis of neurosyphilis but, of these, only five studies (50%) stated what assay was used.
Suspected neurosyphilis. Two retrospective studies from Morocco reported on a total of
256 patients clinically suspected to have neurosyphilis [47,48]. In the larger study (n = 201),
neurosyphilis was diagnosed based on a positive CSF VDRL and TPHA. In the smaller study
(n = 55) the authors report patients had a positive CSF serological test for neurosyphilis but do
not provide details on which tests were performed. Dementia was the most commonly clinical
syndrome seen in 56.6% patients (n = 145) followed by meningovascular syphilis (n = 65,
25.4%) and tabes dorsalis (n = 29, 11.3%).
A further retrospective study from Morocco included 24 patients with arthropathy sus-
pected to be due to tabes dorsalis. CSF testing was performed using a test for treponemal anti-
bodies but the precise test was not stated. In this study all patients had positive syphilis
serology on serum while 33.3% of patients had positive CSF serology [49].
A retrospective study from South Africa included patients with neurosyphilis diagnosed on
the basis of a positive CSF FTA-ABS seen in a single hospital in the Western Cape region over
a ten-year period. A total of 161 patients were identified. Dementia was the most common
diagnosis (n = 81, 50.9%), followed by meningovascular syphilis (n = 24, 14.9%)[50].
In a prospective study in South Africa[51], 50 patients with suspected neurosyphilis were
enrolled. All patients were seropositive for syphilis and clinically diagnosed with tertiary neu-
rosyphilis although detailed clinical information was not provided. All underwent lumbar
puncture. Forty patients (80%) had reactive CSF serology (70% VDRL and FTA-ABS, 10%
FTA-ABS alone) and a further 5 patients (10%) had a positive CSF PCR but negative CSF
serology.
Finally, a case-series from a single centre in Guinea reported 28 patients who were diag-
nosed with neurosyphilis on the basis of both a positive CSF VDRL and CSF-TPHA [52]. The
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series included a broad spectrum of neurological presentations including three cases of facial
nerve palsy, four cases of optic atrophy, eleven cases of seizures, three cases of cerebellar ataxia,
two cases of vestibular-cochlear nerve dysfunction and five cases of clinical meningitis.
Ocular syphilis. A retrospective study from South Africa included patients clinically diag-
nosed with ocular syphilis (n = 68), all of whom had positive serum serology results. Four
cases were known to be HIV positive, one HIV negative, and the status was unknown for the
remaining three cases. Thirty-one (45.6%) patients underwent lumbar puncture (not all of
whom had CSF serologica testing) and, of these, a quarter (n = 8) had CSF findings felt to be
consistent with neurosyphilis [53]. In five cases this was a reactive CSF FTA-ABS and, in three
cases, this was a CSF lymphocyic pleocytosis.
Individuals with HIV and syphilis co-infection. Three studies were identified reporting
on the prevalence of neurosyphilis in individuals with HIV. In a study assessing treatment of
HIV co-infected individuals in Mozambique[54], twenty-one patients with latent syphilis
underwent lumbar puncture at baseline. Four patients (19%) were diagnosed with asymptom-
atic neurosyphilis. None had a positive CSF RPR, all had elevated CSF protein and two had a
CSF pleocytosis (WBC > 5/mm3). As all patients were co-infected with HIV the significance
of a pleocystosis greater than 5/mm3 is uncertain. All patients were re-examined at 3, 6 and 12
months. At six months follow-up one patient still had an abnormal CSF (elevated protein and
pleocyosis) but no patients had an abnormal CSF by twelve months.
In a study conducted between 2000 and 2001, 31 patients with syphilis and HIV co-infec-
tion were seen at a dermatology clinic in Nigeria. All had early syphilis (primary syphilis = 9,
secondary syphilis = 20 and latent syphilis = 2). The authors report that no cases of neurosy-
philis were seen, but details are not provided on what proportion of patients underwent CSF
examination[55].
Finally, in a study of 506 consecutive HIV infected patients in Johannesburg only one case
of neurosyphilis was identified [56], but neither the prevalence of syphilis nor the number of
patients who underwent lumbar puncture is given, so the interpretation of this finding is
extremely limited.
Diagnostic criteria
CSF diagnostic criteria varied across studies (Table 4). The most commonly used criteria were
CSF VDRL alone (n = 14 studies) followed by CSF VDRL combined with either a CSF TPHA
(n = 9 studies) or FTA-ABS (n = 2 studies). Two studies defined neurosyphilis as reactive CSF
FTA-ABS with or without pleocytosis and two studies used the RPR and TPHA assays on CSF.
One study defined neurosyphilis as any one of an abnormal CSF protein, white cell count or
CSF RPR assay. Ten studies stated that CSF was tested using serological assays but did not
clearly state which diagnostic test was used.
Discussion
This is the first systematic review of the literature on neurosyphilis in Africa. The methodologi-
cal quality of the majority of the studies was poor and as such limited conclusions can be
drawn. The available data are clearly inadequate data to robustly estimate the prevalence of
neurosyphilis in Africa or the proportion of cases of important neurological syndromes due to
neurosyphilis. The data are also inadequate to address any potential interaction between HIV
and syphilis in this setting.
Whilst HIV has been reported in Africa since the 1980s we restricted our search to papers
published after 1990. By this point the HIV epidemic was fully established and any impact of
HIV on the risk of neurosyphilis might be anticipated o have become apparent. Whilst we
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used comprehensive search and MESH terms to identify papers it is possible that some studies
on oto-syphilis or other forms of neurosyphilis, or studies which did not explicitly mention
Africa (or an African country) might have been missed. Despite these limitations, we believe
our comprehensive search strategy is likely to have identified nearly all the relevant research
papers for this systematic review.
A major methodological failing of many studies was an inadequate approach to diagnostic
criteria for neurosyphilis. A number of studies included only serum testing without CSF exam-
ination, whilst others did not adequately report the specific CSF assay performed. In part, this
may reflect the lack of an adequate gold-standard. There is a clear need to better define stan-
dards for use in routine diagnosis in low-resource settings, but also for use in research studies.
The studies on patients presenting with stroke are all limited by methodological weak-
nesses. Across these studies there appears to be a consistent association between positive
serum syphilis serology and stroke but, as only a minority of studies undertook CSF examina-
tion, these studies are difficult to interpret, and whether this reflects neurosyphilis is uncertain.
It is possible that the association truly reflects meningovascular syphilis, emboli due to cardio-
vascular syphilis, or confounding factors. Further studies are needed to better delineate the
role of syphilis as a cause of stroke in Africa.
Studies from Morocco continue to report late-stage neurosyphilis, but the majority of stud-
ies are of low methodological quality. In comparison there appear to be few cases of tertiary
neurosyphilis reported from sub-Saharan Africa. Given the weaknesses of most of the studies
it is extremely uncertain whether this represents a true difference in the frequency of tertiary
neurosyphilis or simply reflects reporting/publication bias or lack of access to medical
resources for diagnosis. It has been hypothesised that the ease of access to short courses of pen-
icillin in the community may have altered the natural history of syphilis, resulting in a lower
frequency of late stage manifestations, but this would not explain why cases continue to be
seen in North Africa but not sub-Saharan Africa.
There was a small number of higher quality prospective studies enrolling patients with sus-
pected meningitis, in which neurosyphilis was identified [43,45]. These studies had clear inclu-
sion criteria, included adequate data on denominators, and clear diagnostic criteria for
neurosyphilis. In these studies the prevalence of neurosyphilis was approximately 3%. In these
studies the frequency of neurosyphilis was similar to that of S.pneumoniae as a cause of meningi-
tis, which likely reflects that patients predominantly had subacute meningitis. This would make
syphilis an important and treatable cause of meningitis in Africa. Given the limitations of CSF
serological assays, it is likely that the true proportion of meningitis due to neurosyphilis is higher.
The clinical epidemiology of neurosyphilis in Africa remains poorly understood and the
majority of studies included in this review were of low methodological quality. Inadequate
diagnostics remain a major barrier to progress in our understanding of these important dis-
eases. Future well-designed prospective studies are needed to better delineate the incidence
and clinical spectrum of neurosyphilis in Africa.
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